These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 21649972)
21. SuperGenerics: a better alternative for biogenerics. Charles SA Drug Discov Today; 2005 Apr; 10(8):533-5. PubMed ID: 15837591 [No Abstract] [Full Text] [Related]
22. Initial responses to recommendations of the Blue Ribbon Committee on Generic Medicines. Heller WM Am J Hosp Pharm; 1993 Feb; 50(2):318-22. PubMed ID: 8480792 [No Abstract] [Full Text] [Related]
23. Generic drugs. Save money--but is there a cost? Roberts SS Diabetes Forecast; 2002 Nov; 55(11):51-3. PubMed ID: 14768605 [No Abstract] [Full Text] [Related]
24. Trying times for generic medicines in the USA. Lancet; 2013 Mar; 381(9872):1072. PubMed ID: 23540840 [No Abstract] [Full Text] [Related]
25. [Generic drugs]. Lemye R Rev Med Brux; 2000 Sep; 21(4):A273-5. PubMed ID: 11068479 [TBL] [Abstract][Full Text] [Related]
26. United States Food and Drug Administration requirements for approval of generic drug products. Meyer MC J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846 [TBL] [Abstract][Full Text] [Related]
27. [Generic drugs in morocco: survey of physicians]. Zaoui S; Hakkou F; Filali H Therapie; 2011; 66(6):499-506. PubMed ID: 22186075 [TBL] [Abstract][Full Text] [Related]
28. Save green, go generic: be prepared to answer the $4 question. Hansen D S D Med; 2009 Nov; 62(11):436-7. PubMed ID: 20128174 [No Abstract] [Full Text] [Related]
29. Generic and branded drugs for the treatment of people living with HIV/AIDS. Bartlett JA; Muro EP J Int Assoc Physicians AIDS Care (Chic); 2007 Mar; 6(1):15-23. PubMed ID: 17329500 [TBL] [Abstract][Full Text] [Related]
30. [Free drug samples for doctors? no, thank you!]. Naldi L Recenti Prog Med; 2014 Nov; 105(11):403-4. PubMed ID: 25424231 [TBL] [Abstract][Full Text] [Related]
31. Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use. Shrank WH; Stedman M; Ettner SL; DeLapp D; Dirstine J; Brookhart MA; Fischer MA; Avorn J; Asch SM J Gen Intern Med; 2007 Sep; 22(9):1298-304. PubMed ID: 17647066 [TBL] [Abstract][Full Text] [Related]
32. Global AIDS trial denied patients as US balks at generic drug use. Check E Nature; 2004 Sep; 431(7008):493. PubMed ID: 15457219 [No Abstract] [Full Text] [Related]
35. The Safety of Generic Prescription Drugs in the United States. Singh S Drug Saf; 2018 Apr; 41(4):325-328. PubMed ID: 29313311 [No Abstract] [Full Text] [Related]
36. Determinants of generic entry in the regulated Taiwanese prescription drug market. Liu YM; Cheng JS Health Policy; 2012 Dec; 108(2-3):228-35. PubMed ID: 23020970 [TBL] [Abstract][Full Text] [Related]
37. Similar concerns. Safety, costs among the issues to be weighed as FDA grapples with crafting an approval process for generic versions of biological medicines. Daly R Mod Healthc; 2011 Jul; 41(28):38-40. PubMed ID: 21853593 [No Abstract] [Full Text] [Related]
38. [Beer-Fick criteria and generic drugs in Brazil]. Gorzoni ML; Fabbri RM; Pires SL Rev Assoc Med Bras (1992); 2008; 54(4):353-6. PubMed ID: 18719795 [TBL] [Abstract][Full Text] [Related]
39. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds. McCarthy M BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964 [No Abstract] [Full Text] [Related]
40. FDA comments on activities in states concerning narrow-therapeutic-index drugs. Am J Health Syst Pharm; 1998 Apr; 55(7):686-7. PubMed ID: 9558425 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]